US Patent Issued to KPC PHARMACEUTICALS on Aug. 19 for "Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,653, issued on Aug. 19, was assigned to KPC PHARMACEUTICALS INC (Yunnan, China).

"Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor" was invented by Yaxian Cai (Shanghai), Bao Yue (Shanghai), Peng Yu (Shanghai), Changqing Wei (Shanghai) and Wenyuan Qian (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A salt form and crystal form of a mutant IDHI inhibitor and a preparation method therefor."

The patent was filed on Dec. 22, 2020, under Application No. 17/787,680.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=...